Mechanisms of vascular dysfunction in mice with endothelium-specific deletion of the PPAR-delta gene

Peroxisome proliferator-activated receptor (PPAR)-δ is a nuclear hormone receptor that is mainly involved in lipid metabolism. Recent studies have suggested that PPAR-δ agonists exert vascular protective effects. The present study was designed to characterize vascular function in mice with genetic inactivation of PPAR-δ in the endothelium. Mice with vascular endothelial cell-specific deletion of the PPAR-δ gene (ePPARδ(-/-) mice) were generated using loxP/Cre technology. ePPARδ(-/-) mice were normotensive and did not display any sign of metabolic syndrome. Endothelium-dependent relaxations to ACh and endothelium-independent relaxations to the nitric oxide (NO) donor diethylammonium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolate were both significantly impaired in the aorta and carotid arteries of ePPARδ(-/-) mice (P < 0.05). In ePPARδ(-/-) mouse aortas, phosphorylation of endothelial NO synthase at Ser(1177) was significantly decreased (P < 0.05). However, basal levels of cGMP were unexpectedly increased (P < 0.05). Enzymatic activity of GTP-cyclohydrolase I and tetrahydrobiopterin levels were also enhanced in ePPARδ(-/-) mice (P < 0.05). Most notably, endothelium-specific deletion of the PPAR-δ gene significantly decreased protein expressions of catalase and glutathione peroxidase 1 and resulted in increased levels of H2O2 in the aorta (P < 0.05). In contrast, superoxide anion production was unaltered. Moreover, treatment with catalase prevented the endothelial dysfunction and elevation of cGMP detected in aortas of ePPARδ(-/-) mice. The findings suggest that increased levels of cGMP caused by H2O2 impair vasodilator reactivity to endogenous and exogenous NO. We speculate that chronic elevation of H2O2 predisposes PPAR-δ-deficient arteries to oxidative stress and vascular dysfunction.

[1]  K. Alitalo,et al.  Activation of Hypoxia Response in Endothelial Cells Contributes to Ischemic Cardioprotection , 2013, Molecular and Cellular Biology.

[2]  S. Younkin,et al.  Activation of PPARδ prevents endothelial dysfunction induced by overexpression of amyloid-β precursor protein. , 2012, Cardiovascular research.

[3]  L. d’Uscio,et al.  PPARδ agonist GW501516 prevents uncoupling of endothelial nitric oxide synthase in cerebral microvessels of hph-1 mice , 2012, Brain Research.

[4]  J. Cooke,et al.  PPARδ Activation Protects Endothelial Function in Diabetic Mice , 2012, Diabetes.

[5]  R. Printz,et al.  Neuron-Specific Deletion of Peroxisome Proliferator-Activated Receptor Delta (PPARδ) in Mice Leads to Increased Susceptibility to Diet-Induced Obesity , 2012, PloS one.

[6]  J. Tamargo,et al.  Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-&bgr; Activation in Spontaneously Hypertensive Rats , 2011, Hypertension.

[7]  Leslie A. Smith,et al.  Differential effects of eNOS uncoupling on conduit and small arteries in GTP-cyclohydrolase I-deficient hph-1 mice. , 2011, American journal of physiology. Heart and circulatory physiology.

[8]  K. Wagner,et al.  Peroxisome proliferator‐activated receptor β/δ (PPARβ/δ) is highly expressed in liposarcoma and promotes migration and proliferation , 2011, The Journal of pathology.

[9]  R. Webb,et al.  Interleukin-10 inhibits the in vivo and in vitro adverse effects of TNF-alpha on the endothelium of murine aorta. , 2010, American journal of physiology. Heart and circulatory physiology.

[10]  Huan Yang,et al.  Peroxisome Proliferator-Activated Receptor &dgr; Is an Essential Transcriptional Regulator for Mitochondrial Protection and Biogenesis in Adult Heart , 2010, Circulation research.

[11]  J. Boyle,et al.  PPARdelta and PGC1alpha act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress. , 2010, Cardiovascular research.

[12]  J. Ritzenthaler,et al.  Disruption of endothelial peroxisome proliferator-activated receptor-gamma reduces vascular nitric oxide production. , 2009, American journal of physiology. Heart and circulatory physiology.

[13]  Nanping Wang.  PPAR-δ in Vascular Pathophysiology , 2009, PPAR research.

[14]  Yong Xia,et al.  Bidirectional Actions of Hydrogen Peroxide on Endothelial Nitric-oxide Synthase Phosphorylation and Function , 2008, Journal of Biological Chemistry.

[15]  Song Li,et al.  Peroxisome proliferator-activated receptor delta-agonist, GW501516, ameliorates insulin resistance, improves dyslipidaemia in monosodium L-glutamate metabolic syndrome mice. , 2008, Basic & clinical pharmacology & toxicology.

[16]  R. Evans,et al.  PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis , 2008, Proceedings of the National Academy of Sciences.

[17]  T. Willson,et al.  Activation of Peroxisome Proliferator–Activated Receptor (PPAR)δ Promotes Reversal of Multiple Metabolic Abnormalities, Reduces Oxidative Stress, and Increases Fatty Acid Oxidation in Moderately Obese Men , 2008, Diabetes.

[18]  XianWang,et al.  Suppression of Pro-inflammatory Adhesion Molecules by PPAR-δ in Human Vascular Endothelial Cells , 2008 .

[19]  S. Chien,et al.  Suppression of Pro-inflammatory Adhesion Molecules by PPAR-&dgr; in Human Vascular Endothelial Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[20]  M. Moskowitz,et al.  The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. , 2007, The Journal of clinical investigation.

[21]  B. Staels,et al.  Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors , 2007, Nature Clinical Practice Endocrinology &Metabolism.

[22]  J. Plutzky,et al.  Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. , 2007, Circulation.

[23]  J. Redondo,et al.  Activation of PPAR&bgr;/&dgr; Induces Endothelial Cell Proliferation and Angiogenesis , 2007 .

[24]  L. Kuo,et al.  Upregulation of Arginase by H2O2 Impairs Endothelium-Dependent Nitric Oxide–Mediated Dilation of Coronary Arterioles , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[25]  J. Keaney,et al.  Hydrogen peroxide restrains endothelium-derived nitric oxide bioactivity -- role for iron-dependent oxidative stress. , 2006, Free radical biology & medicine.

[26]  Hong Yang,et al.  Retardation of Atherosclerosis by Overexpression of Catalase or Both Cu/Zn-Superoxide Dismutase and Catalase in Mice Lacking Apolipoprotein E , 2004, Circulation research.

[27]  Michael D. Schneider,et al.  Cardiomyocyte-restricted peroxisome proliferator-activated receptor-δ deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy , 2004, Nature Medicine.

[28]  Johan Auwerx,et al.  Activation of peroxisome proliferator-activated receptor δ induces fatty acid β-oxidation in skeletal muscle and attenuates metabolic syndrome , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Gutterman,et al.  Mechanism of dilation to reactive oxygen species in human coronary arterioles. , 2003, American journal of physiology. Heart and circulatory physiology.

[30]  William A. Boisvert,et al.  Transcriptional Repression of Atherogenic Inflammation: Modulation by PPARδ , 2003, Science.

[31]  Sui Zhang,et al.  Insulin-Stimulated Hydrogen Peroxide Increases Guanylate Cyclase Activity in Vascular Smooth Muscle , 2003, Hypertension.

[32]  Shinichiro Yamamoto,et al.  Hydrogen peroxide stimulates tetrahydrobiopterin synthesis through the induction of GTP-cyclohydrolase I and increases nitric oxide synthase activity in vascular endothelial cells. , 2003, Free radical biology & medicine.

[33]  R. Evans,et al.  Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity , 2003, Cell.

[34]  M. Mori,et al.  Mechanisms underlying the hydrogen peroxide-induced, endothelium-independent relaxation of the norepinephrine-contraction in guinea-pig aorta. , 2003, European journal of pharmacology.

[35]  Leslie A. Smith,et al.  Long-Term Vitamin C Treatment Increases Vascular Tetrahydrobiopterin Levels and Nitric Oxide Synthase Activity , 2003, Circulation research.

[36]  L. Oberley,et al.  Deficiency of Glutathione Peroxidase-1 Sensitizes Hyperhomocysteinemic Mice to Endothelial Dysfunction , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[37]  F. Domann,et al.  Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter. , 2002, Molecular endocrinology.

[38]  R. Evans,et al.  Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Leslie A. Smith,et al.  Hypercholesterolemia Impairs Endothelium-Dependent Relaxations in Common Carotid Arteries of Apolipoprotein E-Deficient Mice , 2001, Stroke.

[40]  Leslie A. Smith,et al.  Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[41]  K. Hirata,et al.  Mechanisms of reduced nitric oxide/cGMP-mediated vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. , 2000, Hypertension.

[42]  J. Ward,et al.  Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) , 2000, Molecular and Cellular Biology.

[43]  J. Auwerx,et al.  Activation of PPARδ alters lipid metabolism in db/db mice , 2000 .

[44]  I. Kang,et al.  The effects of oxygen radicals on the activity of nitric oxide synthase and guanylate cyclase , 1998, Experimental & Molecular Medicine.

[45]  H. Glauert,et al.  Liver-specific catalase expression in transgenic mice inhibits NF-kappaB activation and DNA synthesis induced by the peroxisome proliferator ciprofibrate. , 1998, Carcinogenesis.

[46]  Z. Katušić,et al.  Mechanisms of Cerebral Arterial Relaxations to Hydrogen Peroxide , 1998, Stroke.

[47]  J. Zweier,et al.  Hydrogen peroxide induces intracellular calcium oscillations in human aortic endothelial cells. , 1998, Circulation.

[48]  P. Vanhoutte,et al.  cGMP mediates the desensitization to bradykinin in isolated canine coronary arteries. , 1995, The American journal of physiology.

[49]  S. Milstien,et al.  Regulation of nitric oxide synthesis by proinflammatory cytokines in human umbilical vein endothelial cells. Elevations in tetrahydrobiopterin levels enhance endothelial nitric oxide synthase specific activity. , 1994, The Journal of clinical investigation.

[50]  M. Wolin,et al.  Hydrogen peroxide-induced pulmonary vasodilation: role of guanosine 3',5'-cyclic monophosphate. , 1991, The American journal of physiology.

[51]  Paul M. Vanhoutte,et al.  The Endothelium: Modulator of Cardiovascular Function , 1990 .

[52]  S. Moncada,et al.  Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.

[53]  Robert M. Rapoport,et al.  Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation , 1983, Nature.

[54]  J. Boyle,et al.  PPAR d and PGC 1 a act cooperatively to induce haem oxygenase-1 and enhance vascular endothelial cell resistance to stress , 2010 .

[55]  L. d’Uscio,et al.  Vascular protection by tetrahydrobiopterin: progress and therapeutic prospects. , 2009, Trends in pharmacological sciences.

[56]  I. Édes,et al.  H2O2 increases production of constrictor prostaglandins in smooth muscle leading to enhanced arteriolar tone in Type 2 diabetic mice. , 2007, American journal of physiology. Heart and circulatory physiology.

[57]  R. Ross,et al.  Cell biology of atherosclerosis. , 1995, Annual review of physiology.

[58]  H. Aebi,et al.  Catalase in vitro. , 1984, Methods in enzymology.